These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3012375

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
    Porcellati S, Costantini V, Prosdocimi M, Pistolesi R, Porrovecchio P, Nenci GG, Goracci G.
    Thromb Res; 1987 Jul 01; 47(1):15-24. PubMed ID: 3116710
    [Abstract] [Full Text] [Related]

  • 4. Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets.
    Galli C, Agradi E, Petroni A, Socini A.
    Pharmacol Res Commun; 1980 Apr 01; 12(4):329-37. PubMed ID: 7393988
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
    Prosdocimi M, Finesso M, Tessari F, Gorio A, Languino LR, de Gaetano G, Dejana E.
    Thromb Res; 1985 Aug 15; 39(4):399-409. PubMed ID: 3840290
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.
    Hakim G, Fiorentini D, Falasca A, Prosdocimi M, Rossi CA.
    Experientia; 1988 Mar 15; 44(3):226-8. PubMed ID: 2832208
    [Abstract] [Full Text] [Related]

  • 9. Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man.
    Luzzatto G, Fabris F, Dal Bo Zanon R, Girolami A.
    Arzneimittelforschung; 1986 Jun 15; 36(6):972-3. PubMed ID: 2943294
    [Abstract] [Full Text] [Related]

  • 10. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S, Westwick J, Kakkar VV.
    Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666
    [Abstract] [Full Text] [Related]

  • 11. The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin.
    Porcellati S, Costantini V, Prosdocimi M, Stasi M, Pistolesi R, Nenci GG, Goracci G.
    Agents Actions; 1990 Mar 01; 29(3-4):364-73. PubMed ID: 2111085
    [Abstract] [Full Text] [Related]

  • 12. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP, Maguire MH.
    Br J Pharmacol; 1984 May 01; 82(1):61-72. PubMed ID: 6428500
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of labetalol on human platelet function.
    Anfossi G, Trovati M, Lanzio M, Mularoni E, Massucco P, Emanuelli G.
    Clin Exp Pharmacol Physiol; 1988 Jun 01; 15(6):437-48. PubMed ID: 2856060
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
    de Clerck F, David JL, Janssen PA.
    Agents Actions; 1982 Jul 01; 12(3):388-97. PubMed ID: 6215842
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of human platelet function in vitro and ex vivo by acetaminophen.
    Lages B, Weiss HJ.
    Thromb Res; 1989 Mar 15; 53(6):603-13. PubMed ID: 2499947
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation.
    Ko FN, Yeh LJ, Liang HC, Kuo SC, Teng CM.
    J Pharm Pharmacol; 1996 Apr 15; 48(4):395-400. PubMed ID: 8794990
    [Abstract] [Full Text] [Related]

  • 18. Observations on the effects of some antiaggregating drugs on platelet specific protein discharge after a very weak stimulus.
    Weber G, Bianciardi G, Toti P, Massari P, Orlando P.
    Pharmacol Res Commun; 1985 Feb 15; 17(2):129-35. PubMed ID: 3158006
    [Abstract] [Full Text] [Related]

  • 19. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
    Nichols AB, Owen J, Grossman BA, Marcella JJ, Fleisher LN, Lee MM.
    Circulation; 1984 Nov 15; 70(5):843-50. PubMed ID: 6237807
    [Abstract] [Full Text] [Related]

  • 20. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
    Hardisty RM, Machin SJ, Nokes TJ, Rink TJ, Smith SW.
    Br J Haematol; 1983 Apr 15; 53(4):543-57. PubMed ID: 6830700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.